Nisa Investment Advisors LLC Has $96.80 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Nisa Investment Advisors LLC grew its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 2.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 364,899 shares of the financial services provider's stock after acquiring an additional 7,600 shares during the quarter. Nisa Investment Advisors LLC owned 0.10% of CME Group worth $96,804,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of CME. SeaCrest Wealth Management LLC raised its stake in shares of CME Group by 3.0% during the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after purchasing an additional 40 shares in the last quarter. New Age Alpha Advisors LLC increased its stake in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares during the period. Wealthcare Advisory Partners LLC raised its position in shares of CME Group by 3.6% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after buying an additional 47 shares in the last quarter. Koshinski Asset Management Inc. lifted its stake in shares of CME Group by 1.4% in the 1st quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock worth $934,000 after acquiring an additional 48 shares during the period. Finally, Berry Wealth Group LP lifted its stake in shares of CME Group by 0.4% in the 1st quarter. Berry Wealth Group LP now owns 13,561 shares of the financial services provider's stock worth $3,598,000 after acquiring an additional 49 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Stock Up 0.0%

Shares of CME stock traded up $0.01 on Wednesday, reaching $275.64. 2,841,477 shares of the company's stock traded hands, compared to its average volume of 2,196,408. The company has a market capitalization of $99.33 billion, a P/E ratio of 27.73, a price-to-earnings-growth ratio of 3.83 and a beta of 0.44. CME Group Inc. has a 12-month low of $193.17 and a 12-month high of $290.79. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The business's 50 day moving average price is $276.76 and its two-hundred day moving average price is $258.61.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The company had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.50 EPS. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.81%. The ex-dividend date was Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.

Analyst Upgrades and Downgrades

CME has been the subject of a number of research analyst reports. Keefe, Bruyette & Woods upped their target price on CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. Citigroup raised their target price on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Royal Bank Of Canada reissued a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. UBS Group lifted their price objective on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Finally, Bank of America increased their target price on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $259.87.

Insiders Place Their Bets

In related news, insider Derek Sammann sold 4,650 shares of the stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $280.61, for a total value of $1,304,836.50. Following the transaction, the insider owned 8,336 shares in the company, valued at approximately $2,339,164.96. This represents a 35.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Dennis Suskind sold 1,000 shares of the firm's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the transaction, the director directly owned 2,915 shares in the company, valued at approximately $790,781.20. The trade was a 25.54% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,400 shares of company stock valued at $3,680,610 in the last three months. Company insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.